Skip to main content

Heart Attack update - The Latest on Percutaneous Reperfusion Therapy

Posted by attorney James Girards

In June 2010, the American Journal of Cardiology published a recent study related to reperfusion therapy in st-segment heart attack. The study concluded that the shorter the time period from symptoms to clearing of the blockages with balloon/stenting the better the subsequent blood flow, the better the heart pumps, and the better the patient survival. The synopsis from the journal is re-printed here:

In patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention (pPCI), early reperfusion is believed to improve left ventricular systolic function and reduce mortality; however, long-term (>1 year) data are sparse. In the DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) study, 686 patients with ST-segment elevation myocardial infarction were treated with pPCI. Long-term mortality was obtained during 3 years of follow-up. We classified the patients according to the symptom-to-balloon time (40%, and greater 3-year survival in patients with ST-segment elevation myocardial infarction treated with pPCI. In patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention (pPCI), early reperfusion is believed to improve left ventricular systolic function and reduce mortality; however, long-term (>1 year) data are sparse. In the DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) study, 686 patients with ST-segment elevation myocardial infarction were treated with pPCI. Long-term mortality was obtained during 3 years of follow-up. We classified the patients according to the symptom-to-balloon time (40%, and greater 3-year survival in patients with ST-segment elevation myocardial infarction treated with pPCI."

Additional resources provided by the author

Author of this guide:

Was this guide helpful?